Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005461 |
YEM_ID: | YEM-426 |
ID: | TCMBANKHE005461/YEM-426 |
植物拉丁名: |
|
功能与主治: | To reinforce the kidney yang, to strengthen the tendons and bones,and to dispel cold-damp./Impotence seminal cool, limp wilting sinew and bone, cold impediment in lumbus and knees, yang vacuity cold diarrhea. |
药用植物名: | 仙茅 |
药名: | 仙茅 |
来源: | 云南民族药物志：第三卷 |
药用部位: | rhizome |
使用民族: | 阿昌族/白族/布依族/傣族/德昂族/哈尼族/基诺族/景颇族/傈僳族/苗族/佤族/彝族/壮族 |
药味: | Hot; Pungent |
经络: | Spleen; Liver; Kidney |
毒性: | Toxic |
临床特征: | Enhancing the reactivity of rat's pituitary to luteinizing hormone releasing factor and that of ovary to luteinizing hormone, thus promoting the luteinizing action of the hypothalamus-pituitary-ovary system. |
治疗类型: | 补阳药 |
TCM_ID_id: | 7589 |
SymMap_id: | 429 |
TCMSP_id: | 752 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000682 | Curculigoside_qt | curculigoside A_qt | C22H26O11 | 466.44 | |
| TCMBANKIN001514 | Curculigenin C | curculigenin c | C30H50O3 | 458.7 g/mol | CC(CCC=C(C)C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)O)O)C)C)O |
| TCMBANKIN001962 | curculigosaponin K | C48H82O19 | 963.2 g/mol | CC(C)C(CCC(C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)CO)O)O)O)O)O)C)C)O)O | |
| TCMBANKIN002606 | curculigosaponin C | curculigosaponin c | C41H68O13 | 769 g/mol | CC(C)C(=O)CCC(C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)O)O)C)C)OC7C(C(C(CO7)O)O)O |
| TCMBANKIN003538 | curculigosaponin J | 1077.41 | |||
| TCMBANKIN004883 | curculigosaponin L_qt | curculigosaponin K_qt | 476.82 | ||
| TCMBANKIN005669 | 2,3,4,7-tetramethoxyxanthone | 2,3,4,7-tetramethoxy-9-xanthenone; AIDS-073387; AIDS073387; 2,3,4,7-tetramethoxyxanthen-9-one; 9H-Xanthen-9-one, 2,3,4,7-tetramethoxy-; NCI60_014913; NSC643978 | C17H16O6 | 316.3 g/mol | COC1=CC2=C(C=C1)OC3=C(C(=C(C=C3C2=O)OC)OC)OC |
| TCMBANKIN006706 | 2,4-dichloro-5-methoxy-3-methylphenol | 2,4-dichloro-5-methoxy-3-methyl-phenol | C8H8Cl2O2 | 207.05 g/mol | CC1=C(C(=CC(=C1Cl)OC)O)Cl |
| TCMBANKIN007238 | 4-Methylheptane | NSC73953; 67140_FLUKA; FR-2236; Heptane, 4-methyl-; Heptane, 4-methyl- (8CI)(9CI); 589-53-7; NSC 73953; 111023_ALDRICH; EINECS 209-650-1 | C8H18 | 114.23 | CCCC(C)CCC |
| TCMBANKIN007489 | 4-acetyl-2-methyoxy-5-methyltriacontane | C34H68O2 | 509.02 | ||
| TCMBANKIN007812 | Curculigosaponin G_qt | 474.8 | |||
| TCMBANKIN008084 | Daturic acid | 67701-03-5; daturicacid; n-Heptadecylic acid; EINECS 266-928-5; 51610_FLUKA; 67255-22-5; 68424-37-3; NSC3743; (C16-C18)Alkylcarboxylic acid; WLN: QV16; NSC 3743; SDA 19-005-00; 8043-36-5; CH3-[CH2]15-COOH; EINECS 264-123-3; 506-12-7; LMFA01010017; AI3-36481; EINECS 208-027-1; Lead(2+) heptadecanoate; 37231-04-2; Margaric acid; 45237-52-3; n-Heptadecanoic acid; 7722-21-6; 63399-94-0; Heptadecylic acid; n-Heptadecoic acid; 39390-60-8; heptadecoic acid; 8000-11-1; (C16-C18) Alkylcarboxylic acid; daturic acid; C14-C22 Fatty acid residue; Heptadecanoic acid; Margarinsaeure; 8034-57-9; CHEBI:32365; Fatty acids, C14-22; 28829-31-4; 8034-58-0; 1338-46-1; 52051-63-5; EINECS 270-298-7; 8034-56-8; 4-02-00-01193 (Beilstein Handbook Reference); Fatty acids, C16-18; BRN 1781004; 176435-16-8; 45237-51-2; H3500_SIGMA; Margarinic acid | C17H34O2Pb | 478 g/mol | CCCCCCCCCCCCCCCCC(=O)O.[Pb] |
| TCMBANKIN009600 | iycorine | ||||
| TCMBANKIN010053 | 3-methoxy-5-acetyl-31-tritriacontene | (E)-3-(2-methoxybutyl)hentriacont-29-en-2-one; AC1NSY0Y | C36H70O2 | 521.03 | CCC(CC(CCCCCCCCCCCCCCCCCCCCCCCCCC=CC)C(=O)C)OC |
| TCMBANKIN010887 | 4-heptadecyl-3-henicosenol | 549.14 | |||
| TCMBANKIN011163 | corchioside A | corchioside a | C18H26O11 | 418.4 g/mol | CC1=CC(=CC(=C1)OC2C(C(C(C(O2)COC3C(C(C(CO3)O)O)O)O)O)O)O |
| TCMBANKIN011603 | 3,2',4',6'-Tetrahydroxy-4,3'-dimethoxy chalcone | (E)-3-(3-hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxy-3-methoxy-phenyl)prop-2-en-1-one; AC1NT0WJ; 3-(3-hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxy-3-methoxy-phenyl)prop-2-en-1-one; (E)-3-(3-hydroxy-4-methoxyphenyl)-1-(2,4,6-trihydroxy-3-methoxyphenyl)prop-2-en-1-one; 3,2',4',6'-tetrahydroxy-4,3'-dimethoxy chalcone; 3-(3-hydroxy-4-methoxyphenyl)-1-(2,4,6-trihydroxy-3-methoxyphenyl)prop-2-en-1-one | C17H16O7 | 332.3 g/mol | COC1=C(C=C(C=C1)C=CC(=O)C2=C(C(=C(C=C2O)O)OC)O)O |
| TCMBANKIN013420 | 2,3,5-TRIMETHYLPHENANTHRENE | 2,3,5-Trimethyl-phenanthrene; 3674-73-5; Phenanthrene, 2,3,5-trimethyl- | C17H16 | 220.31 | CC1=C2C(=CC=C1)C=CC3=C2C=C(C(=C3)C)C |
| TCMBANKIN014897 | ZINC03982454 | (3R,8S,9S,10R,13R,14R,17R)-17-[(2R,5S)-5-ethyl-6-methyl-heptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3R,8S,9S,10R,13R,14R,17R)-17-[(1R,4S)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3R,8S,9S,10R,13R,14R,17R)-17-[(1R,4S)-4-ethyl-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3R,8S,9S,10R,13R,14R,17R)-17-[(2R,5S)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | C29H50O | 414.71 | |
| TCMBANKIN015374 | curculigosaponin F | curculigosaponin f | C48H80O19 | 961.1 g/mol | CC(C)C(=O)CCC(C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)OC7C(C(C(C(O7)CO)O)O)OC8C(C(C(C(O8)CO)O)O)O)O)O)C)C)O |
| TCMBANKIN015694 | curculigol | 456.83 | |||
| TCMBANKIN017033 | curculigosaponin B | curculigosaponin b | C35H58O8 | 606.8 g/mol | CC(C)C(=O)CCC(C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)O)O)C)C)OC6C(C(C(CO6)O)O)O |
| TCMBANKIN019429 | curculigosaponin E | curculigosaponin e | C47H78O18 | 931.1 g/mol | CC(C)C(=O)CCC(C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)C)C)OC8C(C(C(CO8)O)O)O |
| TCMBANKIN020913 | 3-acetylaconitine | LS-14009 | C36H49NO12 | 687.77 | CCN1CC2(C(CC(C34C2C(C(C31)C5(C6C4(CC(C6OC(=O)C)(C(C5O)OC)O)O)OC(=O)C)OC)OC)OC(=O)C)COC |
| TCMBANKIN021660 | 3,3',5,5'-tetramethoxy-7,9'7',9-diepoxy-lignan-4,4'-di-O-β-D-glucopyranoside | 742.8 | |||
| TCMBANKIN022286 | Curculigenin A | curculigenin a | C30H50O4 | 474.7 g/mol | CC(C)C(=O)CCC(C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)O)O)C)C)O |
| TCMBANKIN022417 | N-acetyl-N-hydroxy-2-carbamic acid methylester | n-acetyl-n-hydroxy-2-carbamicacid methylester | 133.12 | ||
| TCMBANKIN024038 | Cynanuriculoside A_qt | 490.7 | |||
| TCMBANKIN024045 | curculigosaponin L | curculigosaponin l | C42H72O13 | 785 g/mol | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CCC45CC46C(CCC5C3(C)C)C7(CC(C(C7(CC6O)C)C(C)CCC(C(C)C)O)O)C)CO)O)O)O)O)O |
| TCMBANKIN024610 | curculigosaponin M | curculigosaponin m | C53H88O22 | 1077.3 g/mol | CC(CCC=C(C)C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)CO)O)O)O)O)O)C)C)OC9C(C(C(CO9)O)O)O |
| TCMBANKIN026112 | 2,4,6-Trichloro-3-methoxy-5-methylphenol | Phenol, 2,4,6-trichloro-3-methoxy-5-methyl-; 2,4,6-trichloro-3-methoxy-5-methyl-phenol | C19H25Cl3O11 | 535.75 | CC1=C(C(=C(C(=C1Cl)OC)Cl)O)Cl |
| TCMBANKIN027455 | curculigosaponin A | curculigosaponin a | C36H60O9 | 636.9 g/mol | CC(C)C(=O)CCC(C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)O)O)C)C)O |
| TCMBANKIN029311 | curculigosaponin E_qt | curculigosaponin C_qt; curculigosaponin A_qt; curculigosaponin B_qt; curculigosaponin D_qt | 474.8 | ||
| TCMBANKIN029868 | 2-PROPYL-1-HEPTANOL | C10H22O | 158.28 | CCCCCC(CCC)CO | |
| TCMBANKIN030561 | Curculigoside C_qt | 320.32 | |||
| TCMBANKIN030819 | curculigoside | [5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]methyl 2,6-dimethoxybenzoate; [5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,6-dimethoxybenzoate; 2,6-dimethoxybenzoic acid [5-hydroxy-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]methyl ester; [5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-phenyl]methyl 2,6-dimethoxybenzoate; 2,6-dimethoxybenzoic acid [5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-benzyl] ester; Curculigoside; 85643-19-2; beta-D-Glucopyranoside, 2-(((2,6-dimethoxybenzoyl)oxy)methyl)-4-hydroxyphenyl | C22H26O11 | 466.44 | COC1=C(C(=CC=C1)OC)C(=O)OCC2=C(C=CC(=C2)O)OC3C(C(C(C(O3)CO)O)O)O |
| TCMBANKIN031744 | curculigosaponin J_qt | F_curculigosaponin F_qt; curculigosaponin G_qt; curculigosaponin H_qt; curculigosaponin I_qt | 474.8 | ||
| TCMBANKIN032169 | 24s,3β,11α,16β,24-tetrahydroxycycloartanol-3-o-β-d-glucopyranosyl-(1→2)-β-d-gluco-pyranoside | ||||
| TCMBANKIN033678 | caffeine | NCGC00015208-02; DHCplus; KBio2_001781; W222402_ALDRICH; NINDS_000730; EINECS 200-362-1; Spectrum5_000423; BSPBio_001921; KBio1_000730; ACon1_000085; Probes1_000150; Quick-Pep; D00528; AIDS001649; WLN: T56 BN DN FNVNVJ B1 F1 H1; 1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione; SK 65 Compound; NCGC00090699-07; KBio2_006917; Stim; Caffeina [Italian]; 1,3,7-trimethylpurine-2,6-dione; PDSP2_001219; C7731_SIAL; KBioSS_001781; Caffein; Miudol; Nix Nap; nchembio774-comp2; Nodaca; Caffeine (natural); Cafeina; CFF; Caffeine solution; 7-methyltheophylline; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion (coffein); Bio1_000962; TNP00310; 75035_FLUKA; 1,3,7-Trimethyl-2,6-dioxopurine; NCGC00090699-08; Caffeine, anhydrous; Koffein [German]; C1778_SIAL; Dexitac; 3,7-dihydro-1,3,7-trimethyl-1H-purine; 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; Durvitan; PDSP2_001000; MLS001066409; Eldiatric C; SPECTRUM1500155; cafeine; Koffein; NCIOpen2_008255; BRN 0017705; 71701-02-5; C8960_SIAL; Bio1_001451; MLS001056714; Caffeine (USP); caffenium; SPBio_001222; 27602_FLUKA; 95789-13-2; Spectrum3_000321; Cafecon; Thein; NCGC00015208-01; Coffeinum; 1-methyltheobromine; Mettler Toledo Calibration substance ME 18872, Caffeine; Kofein [Czech]; NSC 5036; Spectrum_001301; NCGC00090699-04; Bayer Select Headache Pain; Theine; Guaranine; KBio3_001141; NSC5036; 1,3,7-trimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine; Spectrum2_001261; EU-0100228; Probes2_000128; MEGxp0_001350; Anhydrous caffeine (TN); 1,3,7-Trimethylxanthine; 58-08-2; Caffedrine; C07481; No-Doz; PDSP1_001016; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion; InChI=1/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H; Phensal; Refresh'n; KBio2_004349; AIDS-001649; Tri-Aqua; Lopac0_000228; ZINC00001084; teina; Methyltheobromine; IDI1_000730; Caffeine, synthetic; 5-26-13-00558 (Beilstein); LS-187843; Theophylline Me; 5-26-13-00558 (Beilstein Handbook Reference); Coffein [German]; C6035_SIGMA; HSDB 36; DivK1c_000730; SDCCGMLS-0064595.P001; KBioGR_002325; NCI-C02733; SBB006474; Spectrum4_001782; Coffeine; Anhydrous caffeine; SMR000326667; 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-; Theobromine, 1-methyl-; Theophylline, 7-methyl; MolMap_000054; NCGC00090699-01; Theobromine Me; LS-237; Cafamil; Cafipel; c1094; AI3-20154; SDCCGMLS-0064595.P002; Xanthine, 1,3,7-trimethyl; Bio1_000473; Mateina; Methylxanthine theophylline; FEMA No. 2224; CHEBI:27732; Tirend; component of P-A-C Compound; Caffeine; Organex; NCGC00090699-03; component of Cafergot; CCRIS 1314; Methyltheobromide; Lopac-C-0750; 3,7-dihydro-1,3,7-trimethyl-1H-purine (9CI); Alert-Pep; C0750_SIAL; PDSP1_001235; Anhydrous caffeine (JP15); Vivarin; Caffeine [BAN:JAN]; Coffein; Caffine | C8H10N4O2 | 194.19 | CN1C=NC2=C1C(=O)N(C(=O)N2C)C |
| TCMBANKIN033698 | Curculigoside B_qt | C21H24O11 | 452.41 | ||
| TCMBANKIN034783 | curculigosaponin D | curculigosaponin d | C42H70O14 | 799 g/mol | CC(C)C(=O)CCC(C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)C)C)O |
| TCMBANKIN035510 | curculigosaponin H | 915.25 | |||
| TCMBANKIN035652 | 3-Methoxyanisole | ZINC00388167; Benzene, m-dimethoxy-; NSC8699; FEMA No. 2385; 126306_ALDRICH; W238503_ALDRICH; EINECS 205-783-4; Resorcinol dimethyl ether; AI3-00845; InChI=1/C8H10O2/c1-9-7-4-3-5-8(6-7)10-2/h3-6H,1-2H; 1,3-Dimethoxybenzene; Dimethylether resorcinolu [Czech]; 151-10-0; 28000-65-9; Benzene, 1,3-dimethoxy-; NSC 8699; Dimethyl resorcinol; Dimethylresorcinol; m-Dimethoxybenzene; 83610_FLUKA; Methoxyanisole, m- | C8H10O2 | 138.16 | COC1=CC(=CC=C1)OC |
| TCMBANKIN035718 | curculigosaponin M_qt | 458.8 | |||
| TCMBANKIN035779 | Curculigenin B | curculigenin b | C30H52O4 | 476.7 g/mol | CC(C)C(CCC(C)C1C(CC2(C1(CC(C34C2CCC5C3(C4)CCC(C5(C)C)O)O)C)C)O)O |
| TCMBANKIN035872 | methyl 5-acetyl-1,2,3,5,6-oxatetrazinane-3-carboxylate | 3-acetyl-5-carbomethoxy-2H-3,4,5,6-tetrahydro-1-oxa-2,3,5,6-tetrazine | 190.19 | ||
| TCMBANKIN035971 | 1-Bromo-2-methoxynaphthalene | 1-bromo-2-methoxy-naphthalene; EINECS 222-272-1; AIDS017820; AIDS-017820; 09379_FLUKA; AE-848/30709025; Maybridge3_005134; Naphthalene, 1-bromo-2-methoxy-; ZINC00081029; NSC 110660; SR-01000640482-1; ST5320134; IDI1_016521; 3401-47-6; NSC110660 | C11H9BrO | 237.09 | COC1=C(C2=CC=CC=C2C=C1)Br |
| TCMBANKIN036901 | myristic acid | 1-Tridecanecarboxylic acid; Myristinsaeure; CH3-[CH2]12-COOH; 70079_FLUKA; AI3-15381; LMFA01010014; CH3-[CH2]12-COO(-); NCGC00091068-02; Myristic acid-[9,10-3H]; C06424; Emery 655; myristic acid ; NSC 5028; 70082_FLUKA; C14 fatty acid; ST023797; W276405_ALDRICH; CCRIS 4724; Kortacid 1499; 3uev; TUNFSRHWOTWDNC-UHFFFAOYSA-M; Tetradecanoic acid; EINECS 250-924-5; n-Tetradecoic acid; 4-02-00-01126 (Beilstein Handbook Reference); Hydrofol acid 1495; MYR; BRN 0508624; Myristate; Myristic acid (natural); Tetradecanoate; LS-190125; Crodacid; Myristic acid (8CI); EINECS 208-875-2; Prifac 2942; Myristic acid; AIDS002505; tetradecoate; W276413_ALDRICH; FEMA No. 2764; HSDB 5686; Philacid 1400; CHEBI:28875; Edenor C 14; n-tetradecoate; 45184-05-2; myristicacid; tetradecoic acid; n-Tetradecanoic acid; M3128_SIGMA; AIDS-002505; Univol U 316S; Lead dimyristate; AC1N2PSK; NCGC00091068-01; neo-Fat 14; NSC5028; Tetradecanoic acid (9CI); Hystrene 9014; Myristic acid, pure; M4792_SIGMA; CHEBI:30807; n-Tetradecan-1-oic acid; WLN: QV13; 1-tetradecanecarboxylate; 32112-52-0; n-tetradecan-1-oate; 544-63-8 | C14H28O2 | 228.371 | C([H])([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
| TCMBANKIN037322 | Curculigoside B | 2-beta-D-Glucopyranosyloxy-5-hydroxybenzyl-2'-methoxy-6'-hydroxybenzoate; beta-D-Glucopyranoside, 4-hydroxy-2-(((2-hydroxy-6-methoxybenzoyl)oxy)methyl)phenyl; curculigoside b; 143601-09-6; [5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-phenyl]methyl 2-hydroxy-6-methoxy-benzoate; AC1L317S; CHEMBL403237; 2-hydroxy-6-methoxybenzoic acid [5-hydroxy-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]methyl ester; 2-hydroxy-6-methoxy-benzoic acid [5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-benzyl] ester; [5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2-hydroxy-6-methoxybenzoate; [5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]methyl 2-hydroxy-6-methoxy-benzoate; DTXSID80162478 | C21H24O11 | 452.41 | COC1=CC=CC(=C1C(=O)OCC2=C(C=CC(=C2)O)OC3C(C(C(C(O3)CO)O)O)O)O |
| TCMBANKIN037539 | Yuccagenin | 511-97-7; Yuccagenin; Spirost-5-ene-2,3-diol, (2alpha,3beta,25R)- | 430.62 | ||
| TCMBANKIN038380 | Orcinol-1-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranoside | ||||
| TCMBANKIN038449 | orcinol-1-o-β-d-apiofuranosyl-(1→6)-β-d-glucopyranoside | ||||
| TCMBANKIN039528 | orcinol glucoside | C13H18O7 | 286.278 | c1(O[C@@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])c([H])c(C([H])([H])[H])c([H])c(O[H])c1[H] | |
| TCMBANKIN040175 | 4-acetyl-2-methoxy-5-methyltriacontane | C34H68O2 | |||
| TCMBANKIN041272 | stearic acid | 4-02-00-01206 (Beilstein Handbook Reference); AIDS-049230; Emersol 871; 8039-52-9; 126539-56-8; stearic acid, ion(1-); D00119; octadecoic acid; Hydrofol Acid 150 (VAN); 134503-33-6; Fatty acids C16-18; 68937-76-8; Kam 2000; VLZ 200; Lunac S 98; Glycon S-80; Hy-phi 1205; Lunac YA; Pristerene 9429; Pristerene 4900; Octadecanoic acid (9CI); Hystrene 9718NF; Edenor FHTI; Cetylacetic acid; NAA 173; NSC 25956; Lunac S 90; S 30C S 30C (fatty acid); Neo-Fat 18-61; Dar-chem 14; NSC25956; Edenor HT-JG 60; Octadecanoate; 57485-56-0; Oktadekansaeure; S 300 (fatty acid); Unister NAA 180; Industrene 5016; Prisorine 3508; Hydrofol Acid 150; Hystrene 4516; G 270; Stearic Acid Cherry; Century 1230; 822-16-2 (SODIUM SALT); NCGC00091596-02; Glycon S-90; 85404-83-7; NCGC00091596-01; Stearic acid (JP15/NF); Hystrene 5016; Hy-phi 1303; Glycon S-70; C01530; Octadecansaeure; Neo-Fat 18-55; WO 2 (fatty acid); Pristerene 9559; SA 200; Century 1240; Stearic acid, pure; Sunfat 18S; WO 2; CHEBI:28842; Industrene 5016K; LS-2392; Kam 3000; BRN 0608585; Edenor ST 20; AIDS049230; Lunac 30; EINECS 273-087-8; Emersol 150; 175366_SIAL; 8039-54-1; Fatty acids, C16-20; stearicacid; Stearic acid ion(1-)salt; Stearic acid (8CI); Stearinsaeure; Emersol 153NF; Hydrofol acid 1855; 57-11-4; Lunac S 30; Hystrene T 70; Prisorine 3501; Haimaric MKH(R); Stearex Beads; Groco 55; Hystrene S-97; Neo-Fat 18-54; W303518_ALDRICH; Hydrofol acid 1655; Nonsoul SN 1 (*Sodium salt*); EINECS 200-313-4; 39390-61-9; Emersol 120; EPA Pesticide Chemical Code 079082; Lunac S 20; Octadecanoic acid, ion(1-); 8013-28-3; AI3-00909; Kortacid 1895; FEMA No. 3035; Hystrene S 97; 82497-27-6; Tegostearic 254; SNA-2000 (*Sodium salt*); 1-Heptadecanecarboxylic acid; AC1MHWEJ; STL280244; 27405_RIEDEL; Steric acid; Industrene 9018; Glycon dp; F 3 (lubricant); Hy-phi 1401; Lunac S 50; Emersol 132; Stearic acid, ion(1-) (8CI); CH3-[CH2]16-COO(-); acide octadecanoique; Groco 55l; 73297_FLUKA; Serfax MT 90; Stearic acid [USAN:JAN]; 8039-51-8; acide stearique; Kam 1000; Acidum stearinicul; InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20; 8039-53-0; 17FA; Stearophanic acid; 8037-83-0; Hystrene 7018; FA 1655; Prisorine 3502; Nonsoul SK 1; Hydrofol Acid 1895; Lunac S 40; Stearic acid 50; 8023-06-1; 85679_FLUKA; HSDB 2000; n-Octadecanoate; 400JB9103-88; Glycon tp; Unimac 5680; Loxiol G 20; Stearate; 875D; Octadecanoic acid; Neo-Fat 18-53; octadecanoate (n-C18:0); Radiacid 0427; Emery 871; Vanicol; Vis-Plus; PD 185; EINECS 250-178-0; AKOS022105769; 646-29-7; Edenor ST 1; S 300; Caswell No. 801D; Selosol 920; Tegostearic 272; Isostearic acid EX; A 1760; WLN: QV17; Stearic acid (TN); Pearl stearic; 609343-71-7; Palmitic acid - stearic acid mixture; Emersol 875; Industrene 8718; Hystrene 9718NFFG; NCGC00164255-02; ST023799; LMFA01010018; Groco 54; Edenor C18; Hystrene T-70; Hy-phi 1199; CTK8J8420; n-Octadecanoic acid; Groco 58; Pristerene 4963; Formula 300; AFCO-Chem B 65; CCRIS 2305; Industrene R; Century 1220; S4751_SIGMA; Neo-Fat 18; 58392-66-8; Barolub FTA; Hystrene 9718; CH3-[CH2]16-COOH; STE; 8037-40-9; 30399-84-9; Lunac S 90KC; Hydrofol 1895; Emery 875D; Century 1210; QIQXTHQIDYTFRH-UHFFFAOYSA-M; Neo-Fat 18-59; LS-1388; Groco 59; Humko Industrene R; Hystrene 80; Adeka Fatty Acid SA 910; Stearic acid; Prifac 2918; Emersol 6349; Edenor C 18/98; 3uex; LS-97707; CHEBI:25629; Neo-Fat 18-S; Stearic acid - palmitic acid mixture; Tegostearic 255; C-Lube 10 | C18H36O2 | 284 | C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])= O |
| TCMBANKIN042297 | curculigosaponin I | C48H80O18 | 945 | C1([H])([H])C([H])([H])[C@]2([C@](C2([H])[H])([C@]([H])(O[H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)C([H])(C([H])([H])[H])C([H])([H])[H])[C@@]([ H])(O[H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4([H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@@]6([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H]) [C@@]6([H])O[C@@]7([H])O[C@@]([H])(C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[C@@]8([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]8([H])O[H])[C@@]7([H])O[H] | |
| TCMBANKIN044503 | curculigine B | curculigine b | C19H26Cl2O11 | 501 | C1([H])([H])O[C@@]([H])(OC([H])([H])[C@@]2([H])O[C@@]([H])(Oc3c([H])c(OC([H])([H])[H])c(Cl)c(C([H])([H])[H])c3Cl)[C@]([H])(O[H])[C@@]([H])(O[H])[C@]2([H])O[H])[C@]([H])(O[H])[C@@]1(C([H])([H])O[H])O[H ] |
| TCMBANKIN045971 | curculigosaponin G | curculigosaponin g; curculigosaponin G | C42H70O13 | 783 | C1([H])([H])C([H])([H])[C@]2([C@](C2([H])[H])([C@]([H])(O[H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)C([H])(C([H])([H])[H])C([H])([H])[H])[C@@]([ H])(O[H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4([H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@@]6([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H]) [C@@]6([H])O[C@@]7([H])O[C@@]([H])(C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]7([H])O[H] |
| TCMBANKIN045988 | 3β,11α-Dihydroxy-olean-12-ene | ||||
| TCMBANKIN046524 | Curculigin B | Curguligine B; 2,4-Dichloro-3-methyl-5-methoxyphenol-O-beta-D-apiofuranosyl(1-6)-beta-D-glucopyranoside; AC1L53KA; 2-(2,4-dichloro-5-methoxy-3-methylphenoxy)-6-[[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]oxane-3,4,5-triol; 143601-10-9; Curculigin B | 501.3 g/mol | ||
| TCMBANKIN048466 | Curcumadiol | Cucumadiol; curcumadiol; 1,4-dimethyl-7-(propan-2-yl)-1,2,3,3a,4,5,8,8a-octahydroazulene-1,4-diol; 31946-48-2; AC1NSU0P; 1,4-dimethyl-7-propan-2-yl-2,3,3a,5,8,8a-hexahydroazulene-1,4-diol; 7-ISOPROPYL-1,4-DIMETHYL-2,3,3A,5,8,8A-HEXAHYDROAZULENE-1,4-DIOL | C15H26O2 | 238.37 g/mol | CC(C)C1=CCC(C2CCC(C2C1)(C)O)(C)O |
| TCMBANKIN048984 | 24S,3beta,11alpha,16beta,24-Tetrahydroxycycloartenol-3-O-beta-D-glucopyranosyl-(1-2)-beta-D-glucopyranoside | C43H74O14 | O([C@]1([H])C([H])([H])C([H])([H])[C@@]2([C@@](C2([H])[H])([C@]([H])(O[H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[C@]([H])(O[H])C([H])(C([H])([H])[H] )C([H])([H])[H])[C@]([H])(O[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4([H])C([H])([H])C5([H])[H])[C@@]5([H])C1(C([H])([H])[H])C([H])([H])[H])[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[C@@]7([H] )[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O7)[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O6 | ||
| TCMBANKIN049572 | Curculigoside C | 482.4 g/mol | |||
| TCMBANKIN049686 | cycloartenol | CF58DF82-6B90-40E1-B241-3FA99C98DA64; Cycloartenol; 9,19-Cyclolanost-24-en-3-ol, (3beta)-; C01902; 9beta,19-Cyclo-24-lanosten-3beta-ol; SCHEMBL561141; Cycloarterenol; 469-38-5; NSC 670193 | C30H50O | 426.7 g/mol | CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C |
| TCMBANKIN058112 | curculigine | isocurculigine | C23H28O12 | 496.5 g/mol | C1=CC(=C(C=C1C(C(CCC(=O)C2=CC(=C(C=C2)O)O)OC3C(C(C(C(O3)CO)O)O)O)O)O)O |
| TCMBANKIN058334 | benzene acetaldehyde | benzeneacetaldehyde; HY1; c0210; alpha-Tolyaldehyde; 1-Oxo-2-phenylethane; 107395_ALDRICH; Acetaldehyde,phenyl- (8CI); ZINC00895323; Phenylacetic aldehyde; alpha-Tolualdehyde; NSC406309; alpha-Toluic aldehyde; 2-phenylacetaldehyde; NSC 406309; CHEBI:16424; FEMA No. 2974; 122-78-1; Phenylacetaldehyde solution; .alpha.-Tolualdehyde; W287407_ALDRICH; PHENYLACETALDEHYDE; W287415_ALDRICH; Benzylcarboxaldehyde; .alpha.-Toluic aldehyde; hyacinthin; Acetaldehyde,phenyl-; Phenylethanal; InChI=1/C8H8O/c9-7-6-8-4-2-1-3-5-8/h1-5,7H,6H; NCIOpen2_003602; AI3-02175; 77800_FLUKA; Phenylacetaldehyde (natural); 2-Phenylethanal; Oxophenylethane; Benzeneacetaldehyde; EINECS 204-574-5; C00601; phenylacetaldehyde; Hyacinthin | C8H8O | 120.15 g/mol | C1=CC=C(C=C1)CC=O |
| TCMBANKIN058634 | lycorine | AC-20268; CHEMBL583716; 2-epi-Lycorine; ZINC21992900; AKOS015965245; Licorine; NCI60_003767; UNII-I9Q105R5BU; ST24047513; Amarylline; HMS3402B04; QTL1_000052; AN-24834; HMS1989B04; 3,3a-Didehydrolycoran-1alpha,2beta-diol; NSC-683873; AN-50515; AJ-46629; AX8136904; KBio3_000043; 3,12-[methylenebis(oxy)]-galanthan-1.alpha.,2.beta.-diol; MolPort-000-882-129; Galanthidine; Bio2_000022; KBioSS_000022; Lycorine hydrochloride; DTXSID60197208; NCGC00163413-02; EINECS 207-503-6; KBio2_005158; ZINC3881372; KBio2_000022; AC1L2HYJ; 2,4,5,7,12b,12c-Hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol, (1S,2S,12bS, 12cS)-; CHEBI:6601; SC-19266; CCG-208232; GNF-PF-4974; KBio3_000044; C08532; LS-88398; AC1Q6ZRB; Lycoran-1-alpha,2-beta-diol, 3,3-alpha-didehydro-; MFCD00243111; Lycoran-1alpha,2beta-diol, 3,3a-didehydro- (8CI); SCHEMBL626071; NSC683873; Bio2_000502; (-)-Lycorine; CHEMBL400092; IDI1_033772; KBioGR_000022; KBio2_002590; BDBM50221066; HMS1361B04; NSC-401360; Likorin; MFCD00221746; NSC 401360; NCGC00163413-01; I9Q105R5BU; BSPBio_001302; 9,10-(methylenedioxy)-3,12-didehydrogalanthan-1alpha,2beta-diol; lycorine; MCULE-4471227410; BRD-K64909280-001-02-7; Galanthan-1, 3,4-didehydro-11,12-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1alpha,2beta-diol, 3,3a-didehydro-; 476-28-8; Galanthan-1, 3,12-didehydro-9,10-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1.alpha., 3,3a-didehydro-; BCBcMAP01_000100; NSC401360; HMS1791B04; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)-; ST085774; STOCK1N-67168; SMP1_000184; Narcissine; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)- (9CI); AK115153; 3,2.beta.-diol; 2,5,7,12b,12c-Hexahydro-1H-[1,3]-dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol; AKOS000278045; (-)-lycorine; narcissine | C16H17NO4 | 287.31 g/mol | C1CN2CC3=CC4=C(C=C3C5C2C1=CC(C5O)O)OCO4 |
| TCMBANKIN058737 | Methylheptadienone | 1604-28-0; SBB008066; 2-Methylhepta-2,4-dien-6-one; (3E)-6-methylhepta-3,5-dien-2-one; AI3-25071; FEMA No. 3363; EINECS 216-507-7; W336300_ALDRICH; (3E)-6-Methyl-3,5-heptadien-2-one; ZINC02018343; 6-Methylhepta-3,5-dien-2-one; 6-Methyl-3,5-heptadiene-2-one; 3,5-Heptadien-2-one, 6-methyl-; FR-0833; 16647-04-4; 3,5-Heptadien-2-one, 6-methyl-, (E)-; 6-METHYL-3,5-HEPTADIEN-2-ONE;(e)-6-methyl-3,5-heptadien-2-one; (4E)-8-methylnona-4,7-dien-3-one; AC1NSYFD;6- Methyl- 3, 5- heptadiene-2- one;6-methyl-3,5-heptadiene-2-one;(E)-6-Methyl-3,5-heptadien-2-one | C8H12O | 124.18 g/mol | CC(=CC=CC(=O)C)C |
| TCMBANKIN059088 | DBQ | EINECS 211-946-0; 2,6-ditert-butyl-1,4-benzoquinone; 2,6-ditert-butyl-p-benzoquinone; 719-22-2; 2,6-di-tert-butylbenzo-1,4-quinone; Maybridge1_002204; 2,5-Cyclohexadien-1,4-dione, 2,6-bis(1,1-dimethylethyl)-; 2,6-Di-tert-butylbenzoquinone; 2,6-Di-tert-butylquinone; SR-01000639296-1; 2,6-Di-t-butyl-1,4-benzoquinone; CBMicro_047944; 2,6-ditert-butylcyclohexa-2,5-diene-1,4-dione; BIM-0047946.P001; NSC14448; p-Benzoquinone, 2,6-di-tert-butyl-; CCRIS 7070; 2,6-Di-tert-Butyl-p-benzoquinone; InChI=1/C14H20O2/c1-13(2,3)10-7-9(15)8-11(12(10)16)14(4,5)6/h7-8H,1-6H; 2,6-DI-T-BUTYL-P-BENZOQUINONE; AI3-61049; HSDB 2775; 2,6-bis-(1,1-dimethylethyl)-2,5-cyclohexadiene-1,4-dione; 2,6-Bis(1,1-dimethylethyl)-2,5-cyclohexadiene-1,4-dione; 153931_ALDRICH; 2,5-Cyclohexadiene-1,4-dione, 2,6-bis(1,1-dimethylethyl)-; 2,6-Di-tert-butyl-1,4-benzoquinone; BTB 09891; NSC 14448 | C14H20O2 | 220.31 g/mol | CC(C)(C)C1=CC(=O)C=C(C1=O)C(C)(C)C |
| TCMBANKIN059674 | Curculigin C | C19H25Cl3O11 | 535.75 | CC1=C(C(=C(C(=C1Cl)OC2C(C(C(C(O2)COC3C(C(C(CO3)O)O)O)O)O)O)Cl)OC)Cl | |
| TCMBANKIN059685 | curculigin a | C20H28Cl2O12 | 531.34 g/mol | CC1=C(C(=CC(=C1Cl)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O)OC)Cl | |
| TCMBANKIN059759 | ligustrazine | C8H12N2 | 136.19 g/mol | CC1=C(N=C(C(=N1)C)C)C | |
| TCMBANKIN059829 | 3,4,5-Trimethoxytoluene | C10H14O3 | 182.22 | CC1=CC(=C(C(=C1)OC)OC)OC | |
| TCMBANKIN059917 | methylbenzol | C6H5CH3 | 92.14 g/mol | CC1=CC=CC=C1 | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061029 | myristic acid | C14H28O2 | 228.37 | CCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061045 | PENTADECYLIC ACID | C15H30O2 | 242.4 g/mol | CCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061071 | Ethylpalmitate | C18H36O2 | 284.5 g/mol | CCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN061091 | stearic acid | CH3(CH2)16COOH | 284.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061284 | TETRAMETHYLSUCCINAMIDE | C8H16N2O2 | 172.22 g/mol | CN(C)C(=O)CCC(=O)N(C)C | |
| TCMBANKIN061318 | 4H-Dibenzo(de,g)quinoline, 9-(4,5-dimethoxy-2-((1,2,3,4-tetrahydro-5,6,7-trimethoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)-5,6,6a,7-tetrahydro-1,2,3,10-tetramethoxy-6-methyl-, (S-(R*,R*))- | C43H52N2O10 | 756.9 g/mol | CN1CCC2=C3C1CC4=CC(=C(C=C4C3=C(C(=C2OC)OC)OC)OC)OC5=CC(=C(C=C5CC6C7=CC(=C(C(=C7CCN6C)OC)OC)OC)OC)OC | |
| TCMBANKIN061745 | syringic acid; Syryngic; 1,5-dimethoxy-3-hydroxybenzoicacid; 3,5-dimethoxy-4-hydroxybenzoic acid; Cedar acid | I01-1212; syringicacid; 3,5-dimethoxy-4-oxidanyl-benzoate; CHEBI:132111; 4-hydroxy-3,5-dimethoxybenzoate; c1409; ZB006317; AKOS015888648; A824548; A829374; CJ-01507; AC1OC351; ST51051575; C10833; DivK1c_006581; KBio3_002814; 530-57-4; AI3-24376; 3,5-Dimethoxy-4-hydroxybenzyl acid; S6881_SIGMA; BSPBio_003312; InChI=1/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12; EINECS 208-486-8; Gallic acid 3,5-dimethyl ether; Syringic acid; NSC2129; Spectrum3_001866; 4-10-00-01995 (Beilstein Handbook Reference); 4-Hydroxy-3,5-dimethoxybenzoic acid; SpecPlus_000485; NSC 2129; 4-hydroxy-3,5-dimethoxy-benzoic acid; Spectrum5_000963; ST5214746; KBio1_001525; BRN 2115262; 3,5-Dimethoxy-4-hydroxybenzoic acid; Benzoic acid, 4-hydroxy-3,5-dimethoxy- | C9H10O5 | 198.17 g/mol | COC1=CC(=CC(=C1O)OC)C(=O)O |
| TCMBANKIN061762 | syringaresinol | (+)-Suyringaresinol-di-O-beta-D-glucoside_qt; (+)syringaresinol; (+)-Suyringaresinol-di-O-beta-D-glucoside; liriodendrin_qt; dl-Syringaresinol; syringaresinol diglucoside_qt; dl-sy-ringaresinol; (+)-syringaresinol-O-β-D-glucopyranoside; (+ )-syringaresinol; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenol; 21453-69-0; C10889; (7alpha,7'alpha,8alpha,8'alpha)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane-4,4'-diol; CHEBI:47; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenol; (+)-syringaresinol; (+ )- syringaresinol; dl-syringaresinol; (-)-syringaresinol; episyringaresinol; (+)-syringarosinol; (+ )-Syringaresinol-O-β-D-glucopyranoside; syringaresino; (-)-syringaresinol; (?)-syringaresinol; (+)-Syringaresinol; lirioresinol-A | C34H46O18 | 742.72 | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)O)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab